Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biliary atresia

W Middlesworth1, R P Altman

  • 1Division of Pediatric Surgery, College of Physicians and Surgeons, Columbia University, Babies and Children's Hospital of New York, NY 10022, USA.

Current Opinion in Pediatrics
|June 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel use of an established agent: Topotecan is anti-angiogenic in experimental Wilms tumor.

Journal of pediatric surgery·2001
Same author

Combination antiangiogenic therapy: increased efficacy in a murine model of Wilms tumor.

Journal of pediatric surgery·2001
Same author

All angiogenesis is not the same: Distinct patterns of response to antiangiogenic therapy in experimental neuroblastoma and Wilms tumor.

Journal of pediatric surgery·2001
Same author

Highly specific antiangiogenic therapy is effective in suppressing growth of experimental Wilms tumors.

Journal of pediatric surgery·2001
Same author

Trisomy 1q, 2, and 20 in a case of hepatoblastoma: possible significance of 2q35-q37 and 1q12-q21 rearrangements.

Cancer genetics and cytogenetics·2001
Same author

A multivariable risk factor analysis of the portoenterostomy (Kasai) procedure for biliary atresia: twenty-five years of experience from two centers.

Annals of surgery·1997
Same journal

For health, for beauty, or both? navigating trends as adolescent clinicians.

Current opinion in pediatrics·2026
Same journal

Childhood sleep disorders: practical management for the pediatrician.

Current opinion in pediatrics·2026
Same journal

Advanced therapies in management of pediatric inflammatory bowel disease.

Current opinion in pediatrics·2026
Same journal

Artificial intelligence in pediatric endoscopy for hereditary polyposis syndromes: promises and challenges.

Current opinion in pediatrics·2026
Same journal

Hormonal acne therapies in pediatrics.

Current opinion in pediatrics·2026
Same journal

Clinical implementation of artificial intelligence in adolescent mental healthcare.

Current opinion in pediatrics·2026
See all related articles

Biliary atresia is a fatal newborn liver disease. While Kasai portoenterostomy is standard, liver transplantation offers better outcomes for those it fails to help.

Area of Science:

  • Pediatric Hepatology
  • Gastroenterology
  • Neonatal Medicine

Background:

  • Biliary atresia is a progressive bile duct disease in newborns.
  • It causes cholestasis, fibrosis, cirrhosis, portal hypertension, and liver failure.
  • Without treatment, biliary atresia is fatal.

Purpose of the Study:

  • To review recent advances in understanding biliary atresia (Dec 1995-Nov 1996).
  • To highlight key treatment milestones and current research directions.

Main Methods:

  • Literature review of studies published between December 1995 and November 1996.
  • Focus on characterization of hepatic pathology, causative agents, and outcome predictors.

Main Results:

Related Experiment Videos

  • Kasai portoenterostomy is the standard first-line intervention.
  • Orthotopic liver transplantation offers improved survival for treatment failures.
  • Etiology remains poorly understood, requiring further investigation.

    • Conclusions:

    • Biliary atresia necessitates prompt intervention, with Kasai portoenterostomy as the initial standard.
    • Liver transplantation is crucial for managing advanced cases or treatment failures.
    • Ongoing research aims to elucidate etiology and identify prognostic factors.